GCP
TVRD

GSA Capital Partners’s Tvardi Therapeutics TVRD Stock Holding History

GSA Capital Partners’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,257
Closed -$41K – 2096
2024
Q1 		$41K Sell
1,257
-4,998
-80% -$130K ﹤0.01% 1541
2023
Q4 		$167K Buy
+6,255
New +$259K 0.01% 1357
2023
Q3 		– Sell
-2,269
Closed -$231K – 1989
2023
Q2 		$231K Buy
2,269
+1,643
+262% +$226K 0.02% 1191
2023
Q1 		$111K Buy
+626
New +$210K 0.01% 1347
2022
Q3 		– Sell
-3,348
Closed -$1.1M – 1933
2022
Q2 		$1.1M Buy
3,348
+2,999
+859% +$1.05M 0.17% 107
2022
Q1 		$153K Buy
+349
New +$143K 0.02% 1230
2019
Q4 		– Sell
-474
Closed -$312K – 1782
2019
Q3 		$312K Buy
+474
New +$394K 0.04% 863
2016
Q4 		– Sell
-1,089
Closed -$327K – 2003
2016
Q3 		$327K Buy
+1,089
New +$236K 0.02% 1311
2016
Q2 		– Sell
-1,556
Closed -$348K – 1954
2016
Q1 		$348K Sell
1,556
-974
-38% -$291K 0.02% 1227
2015
Q4 		$1.53M Buy
2,530
+577
+30% +$317K 0.08% 399
2015
Q3 		$1M Buy
+1,953
New +$1.31M 0.05% 620
2015
Q1 		– Sell
-294
Closed -$106K – 2237
2014
Q4 		$106K Sell
294
-256
-47% -$82.4K 0.01% 1583
2014
Q3 		$166K Buy
+550
New +$226K 0.01% 1559

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GSA Capital Partners's TVRD Position: Q2 2024 in Review

GSA Capital Partners sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 1,257 shares — an estimated $41K sold.

GSA Capital Partners first reported a position in TVRD in Q3 2014 and held it in 13 quarters. The position peaked at $1.53M in Q4 2015. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • GSA Capital Partners reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • GSA Capital Partners sold 1,257 Tvardi Therapeutics shares in Q2 2024, an estimated $41K.
  • GSA Capital Partners first reported a position in Tvardi Therapeutics in Q3 2014 and held it in 13 quarters.
  • GSA Capital Partners's Tvardi Therapeutics position peaked at $1.53M in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.